• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D在骨骼中的新作用靶点:维生素D受体在成骨细胞、骨细胞和破骨细胞中的作用

Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts.

作者信息

Ryan Jackson W, Reinke Daniel, Kogawa Masakazu, Turner Andrew G, Atkins Gerald J, Anderson Paul H, Morris Howard A

机构信息

School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide SA 5001, Australia.

出版信息

Curr Drug Targets. 2013 Dec;14(14):1683-8. doi: 10.2174/138945011131400212.

DOI:10.2174/138945011131400212
PMID:24010964
Abstract

The active form of vitamin D, 1,25-dihydroxyvitamin D3, carries out its diverse range of biological activities by binding to the nuclear vitamin D receptor, present in almost every cell of the body. It is well established that adequate serum 25-hydroxyvitamin D levels correlate with a reduction in the incidence of osteoporosis; however, the physiological basis for this relationship remains elusive. Although, the endocrine actions of vitamin D are thoroughly appreciated, the effect of vitamin D on bone tissue and bone cells is yet to be completely understood. There exists a wealth of literature that suggests the VDR within the three major bone cell types, osteoblasts, osteocytes and osteoclasts, is responsible for the regulation of bone homeostasis. The circumstances, under which the action of 1,25-dihydroxyvitamin D3 elicits an anabolic or catabolic role have not been elucidated. However, it would seem that vitamin D can evoke both of these effects and that this is partly mediated by calcium homeostasis. This raises the possibility that dietary calcium intake and vitamin D metabolism act concomitantly at the kidney, intestine and the bone in a coordinated response. Thus, to maintain adequate bone homeostasis and reduce the risk of metabolic bone disease via the diet, it is important to consider this duality of vitamin D action in relation to the overall calcium economy.

摘要

维生素D的活性形式,1,25-二羟基维生素D3,通过与核维生素D受体结合来发挥其广泛的生物活性,该受体存在于人体几乎每个细胞中。充分的血清25-羟基维生素D水平与骨质疏松症发病率的降低相关,这一点已得到充分证实;然而,这种关系的生理基础仍然难以捉摸。尽管维生素D的内分泌作用已得到充分认识,但维生素D对骨组织和骨细胞的影响尚未完全了解。有大量文献表明,三种主要骨细胞类型(成骨细胞、骨细胞和破骨细胞)中的维生素D受体负责骨稳态的调节。1,25-二羟基维生素D3的作用引发合成代谢或分解代谢作用的情况尚未阐明。然而,维生素D似乎可以引发这两种作用,并且这部分是由钙稳态介导的。这就增加了膳食钙摄入量和维生素D代谢在肾脏、肠道和骨骼中协同作用以产生协调反应的可能性。因此,为了通过饮食维持充分的骨稳态并降低代谢性骨病的风险,考虑维生素D作用与整体钙代谢的这种双重性很重要。

相似文献

1
Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts.维生素D在骨骼中的新作用靶点:维生素D受体在成骨细胞、骨细胞和破骨细胞中的作用
Curr Drug Targets. 2013 Dec;14(14):1683-8. doi: 10.2174/138945011131400212.
2
Identification of the vitamin D receptor in osteoblasts and chondrocytes but not osteoclasts in mouse bone.在小鼠骨骼中,成骨细胞和软骨细胞而非破骨细胞中维生素D受体的鉴定。
J Bone Miner Res. 2014 Mar;29(3):685-92. doi: 10.1002/jbmr.2081.
3
VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.维生素 D 受体(VDR)在成骨细胞系细胞中主要通过抑制骨吸收来介导维生素 D 治疗引起的骨量增加。
J Bone Miner Res. 2017 Jun;32(6):1297-1308. doi: 10.1002/jbmr.3096. Epub 2017 Feb 22.
4
Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency.成骨细胞和骨细胞中维生素 D 受体的过度表达可防止维生素 D 缺乏时的骨丢失。
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:128-31. doi: 10.1016/j.jsbmb.2014.01.002. Epub 2014 Jan 13.
5
Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D on the mature osteoblast cell line MLO-A5.外源性和内源性1,25-二羟基维生素D对成熟成骨细胞系MLO-A5生物学效应的比较。
J Steroid Biochem Mol Biol. 2016 Nov;164:374-378. doi: 10.1016/j.jsbmb.2016.03.004. Epub 2016 Mar 4.
6
Vitamin D activities and metabolic bone disease.维生素 D 活性与代谢性骨病。
Clin Chim Acta. 2013 Oct 21;425:148-52. doi: 10.1016/j.cca.2013.07.024. Epub 2013 Jul 30.
7
[Bone and Nutrition. The vitamin D functions in osteoblasts and osteocytes].[骨骼与营养。维生素D在成骨细胞和骨细胞中的作用]
Clin Calcium. 2015 Jul;25(7):991-7.
8
Vitamin D activities for health outcomes.维生素D对健康结果的作用。
Ann Lab Med. 2014 May;34(3):181-6. doi: 10.3343/alm.2014.34.3.181. Epub 2014 Apr 8.
9
Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis.成骨细胞中的维生素 D 信号转导:对骨骼和矿物质稳态的影响。
Bone. 2013 Jun;54(2):237-43. doi: 10.1016/j.bone.2012.10.007. Epub 2012 Oct 13.
10
Vitamin D receptor in osteoblasts is a negative regulator of bone mass control.成骨细胞中的维生素 D 受体是骨量控制的负调节剂。
Endocrinology. 2013 Mar;154(3):1008-20. doi: 10.1210/en.2012-1542. Epub 2013 Feb 6.

引用本文的文献

1
Circulating MicroRNA Expression, Vitamin D, and Hypercortisolism as Predictors of Osteoporosis in Elderly Postmenopausal Women.循环 microRNA 表达、维生素 D 和皮质醇过多症作为老年绝经后妇女骨质疏松症的预测因子。
Dis Markers. 2021 Dec 13;2021:3719919. doi: 10.1155/2021/3719919. eCollection 2021.
2
Treatment of pre-collapse non-traumatic osteonecrosis of the femoral head through Orthopdische Chirurgie München approach combined with autologous bone mixed with β-tricalcium phosphate porous bioceramic bone graft: a retrospective study of mid-term results.通过慕尼黑骨科手术方法联合自体骨混合β-磷酸三钙多孔生物陶瓷骨移植物治疗非创伤性股骨头塌陷前骨坏死:中期结果的回顾性研究。
J Orthop Surg Res. 2021 Aug 12;16(1):492. doi: 10.1186/s13018-021-02632-x.
3
Analysis of Combined Indicators for Risk of Osteoporotic Hip Fracture in Elderly Women.老年女性骨质疏松性髋部骨折风险的联合指标分析。
Orthop Surg. 2021 Jun;13(4):1205-1212. doi: 10.1111/os.12974. Epub 2021 May 4.
4
DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts.1,25D3 诱导的 DKK1 是成骨细胞矿化所必需的。
Cells. 2020 Jan 17;9(1):236. doi: 10.3390/cells9010236.
5
Ageing characteristics of bone indicated by transcriptomic and exosomal proteomic analysis of cortical bone cells.基于皮质骨细胞转录组和外泌体蛋白质组分析的骨老化特征。
J Orthop Surg Res. 2019 May 10;14(1):129. doi: 10.1186/s13018-019-1163-4.
6
The guiding role of bone metabolism test in osteoporosis treatment.骨代谢检测在骨质疏松症治疗中的指导作用。
Am J Clin Exp Immunol. 2018 Apr 5;7(2):40-49. eCollection 2018.
7
Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.当前用于缓解肝脏疾病和癌症的疗法,特别关注维生素D的潜力。
Nutr Metab (Lond). 2018 Feb 9;15:13. doi: 10.1186/s12986-018-0251-5. eCollection 2018.
8
Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.巴勒斯坦绝经后骨质疏松症女性和正常女性的血清25-羟基维生素D及骨转换标志物
Arch Osteoporos. 2017 Dec;12(1):13. doi: 10.1007/s11657-017-0306-7. Epub 2017 Jan 26.
9
The association between Vitamin D and health outcomes in women: A review on the related evidence.维生素D与女性健康结局之间的关联:相关证据综述
J Res Med Sci. 2016 Sep 1;21:76. doi: 10.4103/1735-1995.189693. eCollection 2016.
10
Osteocyte-derived insulin-like growth factor I is not essential for the bone repletion response in mice.骨细胞衍生的胰岛素样生长因子I对小鼠的骨补充反应并非必不可少。
PLoS One. 2015 Jan 30;10(1):e0115897. doi: 10.1371/journal.pone.0115897. eCollection 2015.